ChemMedChem, 2011, 6, 816-825.

Design, synthesis and in vitro antifungal activity of 1-[(4-substituted benzyl)methylamino]-2-(2,4-difluorophenyl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ols.

Bioorg. Med. Chem. Lett., 2010, 20, 5203-5206.

Synthesis of N-aryl-3-(indol-3-yl)propanamides and their immunosuppressive activities.

Bioorg. Med. Chem. Lett., 2009, 19(20), 5833-5836.

Design of new antifungal agents: synthesis and evaluation of 1-[(1H-indol-5-ylmethyl)amino]-2-phenyl-3-(1H-1,2,4-triazol-1-yl)propan-2-ols.

J. Enz. Inh. Med. Chem., 2009, 24(5), 1067-1075.

Design, synthesis and evaluation of 3-(imidazol-1-ylmethyl)indoles as antileishmanial agents. Part II.

Bioorg. Med. Chem. Lett., 2009, 19(2), 301-304

Synthesis and structure-activity relationships of 2-phenyl-1-[(pyridinyl- and piperidinylmethyl)amino]-3-(1H-1,2,4-triazol-1-yl)propan-2-ols as antifungal agents.

Bioorg. Med. Chem. Lett. 2008, 18(6), 1820-1824.

Design, synthesis, and evaluation of 1-(N-benzylamino)-2-phenyl-3-(1H-1,2,4-triazol-1-yl)propan-2-ols as antifungal agents.

Tetrahedron Lett. 2006, 47, 6479-6483.

Efficient microwave-assisted synthesis of 2-phenyl-1-(1H-indol-1-yl)-3-(1H-1,2,4-triazol-1-yl)propan-2-ol derivatives with potential antifungal activity.

Conception rationnelle, synthèse et évaluation de dérivés hétérocycliques azotés à activités antifongique et/ou antileishmanienne.

Nantes, date de soutenance : 9 octobre 2007.